These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 7419687)
1. Plasma lipoproteins during treatment with cyproterone acetate in men with prostatic carcinoma. Wallentin L; Varenhorst E J Clin Endocrinol Metab; 1980 Nov; 51(5):1118-22. PubMed ID: 7419687 [TBL] [Abstract][Full Text] [Related]
2. Plasma lipoproteins during anti-androgen treatment by estrogens or orchidectomy in men with prostatic carcinoma. Wallentin L; Varenhorst E Horm Metab Res; 1981 May; 13(5):293-7. PubMed ID: 7262828 [TBL] [Abstract][Full Text] [Related]
3. Cholesterol ester metabolism in plasma during estrogen and antiandrogen treatment in men with carcinoma of the prostate. Wallentin L; Varenhorst E J Lab Clin Med; 1981 Dec; 98(6):906-16. PubMed ID: 6458644 [TBL] [Abstract][Full Text] [Related]
4. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
6. [Effects of cyproterone acetate on cardiovascular risk factors in patients with carcinoma of the prostate (author's transl)]. Varenhorst E; Karlberg BE; Risberg B; Wallentin L; Wranne B Urologe A; 1981 Jul; 20(4):218-22. PubMed ID: 6455834 [TBL] [Abstract][Full Text] [Related]
7. Effects of cyproterone acetate (CPA) on serum lipoproteins when administered alone and in combination with ethinyl estradiol (EE). Lindberg UB; Crona N; Enk L; Samsioe G; Silfverstolpe G Horm Metab Res; 1987 May; 19(5):222-5. PubMed ID: 2953663 [TBL] [Abstract][Full Text] [Related]
8. Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide. Moorjani S; Dupont A; Labrie F; Lupien PJ; Gagné C; Brun D; Giguère M; Bélanger A; Cusan L J Clin Endocrinol Metab; 1988 Feb; 66(2):314-22. PubMed ID: 3276721 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity. Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786 [TBL] [Abstract][Full Text] [Related]
10. Lipoproteins and cholesterol esterification rate in men and women with hypercholesterolaemia of type IIa. Moberg B; Wallentin L Scand J Clin Lab Invest; 1981 Nov; 41(7):655-61. PubMed ID: 7339867 [TBL] [Abstract][Full Text] [Related]
11. Effects of cyproterone acetate and a long-acting LHRH analogue on serum lipoproteins in patients with carcinoma of the prostate. Paisey RB; Kadow C; Bolton C; Hartog M; Gingell JC J R Soc Med; 1986 Apr; 79(4):210-1. PubMed ID: 2939240 [TBL] [Abstract][Full Text] [Related]
12. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women. Chiuve SE; Martin LA; Campos H; Sacks FM J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543 [TBL] [Abstract][Full Text] [Related]
13. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids. Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383 [TBL] [Abstract][Full Text] [Related]
14. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women. Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090 [TBL] [Abstract][Full Text] [Related]
15. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206 [TBL] [Abstract][Full Text] [Related]
16. Dose and duration effects of estradiol valerate on serum and lipoprotein lipids. Enk L; Crona N; Samsioe G; Silfverstolpe G Horm Metab Res; 1986 Aug; 18(8):551-4. PubMed ID: 3530933 [TBL] [Abstract][Full Text] [Related]
18. Differential changes in plasma high-density lipoprotein-cholesterol levels in obese men and women during weight reduction. Brownell KD; Stunkard AJ Arch Intern Med; 1981 Aug; 141(9):1142-6. PubMed ID: 7259372 [TBL] [Abstract][Full Text] [Related]
19. Paradoxical effects of the anti-androgen cyproterone acetate on lipid and lipoprotein metabolism. Wynn V; Godsland IF; Seed M; Jacobs HS Clin Endocrinol (Oxf); 1986 Feb; 24(2):183-91. PubMed ID: 2940034 [TBL] [Abstract][Full Text] [Related]
20. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population. Jones GJ; Hewitt D; Godin GJ; Breckenridge WC; Bird J; Mishkel MA; Steiner G; Little JA Can Med Assoc J; 1980 Jan; 122(1):37-8, 40-6. PubMed ID: 7363194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]